Weiss Multi-Strategy Advisers’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,621
Closed -$532K 672
2023
Q2
$532K Sell
1,621
-17
-1% -$5.18K 0.01% 575
2023
Q1
$452K Sell
1,638
-1,695
-51% -$622K 0.01% 562
2022
Q4
$1.29M Buy
+3,333
New +$940K 0.04% 433
2022
Q3
Sell
-4,681
Closed -$1.04M 738
2022
Q2
$1.04M Buy
+4,681
New +$2.01M 0.03% 478
2022
Q1
Sell
-664
Closed -$459K 761
2021
Q4
$459K Sell
664
-203
-23% -$150K 0.01% 557
2021
Q3
$643K Sell
867
-147
-14% -$100K 0.01% 531
2021
Q2
$761K Buy
1,014
+351
+53% +$268K 0.02% 521
2021
Q1
$541K Buy
663
+330
+99% +$255K 0.01% 538
2020
Q4
$284K Buy
+333
New +$257K 0.01% 621

Other funds holding OM

Weiss Multi-Strategy Advisers's OM Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of Outset Medical (OM) in Q3 2023, closing a stake of 1,621 shares — an estimated $532K sold.

Weiss Multi-Strategy Advisers first reported a position in OM in Q4 2020 and held it in 9 quarters. The position peaked at $1.29M in Q4 2022. 152 funds tracked by Wall St. Rank hold OM as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Outset Medical position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 1,621 Outset Medical shares in Q3 2023, an estimated $532K.
  • Weiss Multi-Strategy Advisers first reported a position in Outset Medical in Q4 2020 and held it in 9 quarters.
  • Weiss Multi-Strategy Advisers's Outset Medical position peaked at $1.29M in Q4 2022.
  • 152 funds tracked by Wall St. Rank held Outset Medical as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.